Rm. Shaheen et al., COMPARISON OF CATHEPSIN-D DETERMINATIONS IN HUMAN CARCINOMAS BY ENZYME-IMMUNOASSAY AND IMMUNORADIOMETRIC ASSAY, Journal of clinical laboratory analysis, 9(6), 1995, pp. 351-358
Overexpression of cathepsin D in several types of carcinoma in women a
ppears to be associated with a poor clinical course. In this prospecti
ve investigation, cathepsin D levels in 170 specimens of normal and ne
oplastic human tissues were determined simultaneously by enzyme immuno
assay (EIA) and immunoradiometric assay (IRMA) to allow comparisons in
multicentric studies, such as cooperative clinical trials. Nonmaligna
nt uteri and specially prepared reference powders were also evaluated.
Linear regression analysis between the two assays for all specimens [
EIA = 0.87(IRMA) - 3.18] demonstrated a correlation coefficient (r) of
0.99 (P < 0.001). When malignancies were categorized by the tissue or
igin (i.e., breast, uterus, ovary, lymph node, and colon), highly sign
ificant correlations were also observed (regressions slopes ranged fro
m 0.58 to 1.02). Intra- and interassay controls conducted for the new
EIA procedure gave CV% ranging from 4.4 to 10.2, which was similar to
the IRMA test for cathepsin D. The results of both assays correlated w
ell and were highly reproducible. Either assay may be used with confid
ence that comparable cathepsin D values will be obtained in a wide ran
ge of tissue biopsies. (C) 1995 Wiley-Liss, Inc.